Orally administered resveratrol enhances the therapeutic effect of autologous transplanted adipose-derived stem cells on rats with diabetic hepatopathy

References

• Alam U, Asghar O, Azmi S, Malik RA. 2014. General aspects of diabetes mellitus. Handbook of Clinical Neurology Volume . 126:211–222.
   Google Scholar
• Al-Qattan KK, Mansour MH, Thomson M, Ali M. 2016. Garlic decreases liver and kidney receptor for advanced glycation end products expression in experimental diabetes. Pathophysiology. 23:135–145. doi:10.1016/j.pathophys.2016.02.003.
   PubMedGoogle Scholar
• Cardiff RD, Miller CH, Munn RJ. 2014. Manual for hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc. doi:10.1101/pdb.prot073411
   Google Scholar
• Chen TS, Liou SY, Kuo CH, Pan LF, Yeh YL, Liou J, Padma VV, Yao CH, Kuo WW, Huang CY. 2017. Green tea epigallocatechin gallate enhances cardiac function restoration through survival signaling expression in diabetes mellitus rats with autologous adipose tissue-derived stem cells. J Appl Physiol. 123:1081–1091. doi:10.1152/japplphysiol.00471.2016.
   PubMed Web of Science ®Google Scholar
• Coudriet GM, Delmastro-Greenwood MM, Previte DM, Marré ML, O’Connor EC, Novak EA, Vincent G, Mollen KP, Lee S, Dong HH, Piganelli JD. 2017. Treatment with a catalytic superoxide dismutase (SOD) mimetic improves liver steatosis, insulin sensitivity, and inflammation in obesity-induced type 2 diabetes. Antioxidants (Basel). 6:85–102. doi:10.3390/antiox6040085.
   Google Scholar
• Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. 2014. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 34:837–843. doi:10.1016/j.nutres.2014.09.005.
   PubMed Web of Science ®Google Scholar
• Hirsch IB. 2015. Glycemic variability and diabetes complications: does it matter? Of course it does! Diabetes Care. 38:1610–1614. doi:10.2337/dc14-2898.
   PubMed Web of Science ®Google Scholar
• Huynh J, Yamada J, Beauharnais C, Wenger JB, Thadhani RI, Wexler D, Roberts DJ, Bentley-Lewis R. 2015. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta. 36:1161–1166. doi:10.1016/j.placenta.2015.08.004.
   PubMed Web of Science ®Google Scholar
• Jang YO, Kim SH, Cho MY, Kim KS, Park KS, Cha SK, Kim MY, Chang SJ, Baik SK. 2018. Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis. Biochem Biophys Res Commun. 497:264–271. doi:10.1016/j.bbrc.2018.02.067.
   PubMed Web of Science ®Google Scholar
• Li Q, Peng Y, Fan L, Xu H, He P, Cao S, Li J, Chen T, Ruan W, Chen G. 2018. Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway. Biomed Pharmacother. 99:947–955. doi:10.1016/j.biopha.2018.01.093.
   PubMed Web of Science ®Google Scholar
• Moniruzzaman M, Ghosal I, Das D, Chakraborty SB. 2018. Melatonin ameliorates H2O2-induced oxidative stress through modulation of Erk/Akt/NFkB pathway. Biol Res. 51:17. doi:10.1186/s40659-018-0176-5.
   PubMed Web of Science ®Google Scholar
• Motawi TM, Atta HM, Sadik NA, Azzam M. 2014. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis. Cell Biochem Biophys. 68:111–125. doi:10.1007/s12013-013-9698-1.
   PubMed Web of Science ®Google Scholar
• Niyomchan A, Watcharasit P, Visitnonthachai D, Homkajorn B, Thiantanawat A, Satayavivad J. 2015. Insulin attenuates arsenic-induced neurite outgrowth impairments by activating the PI3K/Akt/SIRT1 signaling pathway. Toxicol Lett. 236:138–144. doi:10.1016/j.toxlet.2015.05.008.
   PubMed Web of Science ®Google Scholar
• Park D, Lim J, Park JY, Lee SH. 2015. Concise review: stem cell microenvironment on a chip: current technologies for tissue engineering and stem cell biology. Stem Cells Transl Med. 4:1352–1368. doi:10.5966/sctm.2015-0095.
   PubMed Web of Science ®Google Scholar
• Ren Y, Du C, Shi Y, Wei J, Wu H, Cui H. 2017. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress. Int J Mol Med. 39:1317–1324. doi:10.3892/ijmm.2017.2931.
   PubMed Web of Science ®Google Scholar
• Rochette L, Zeller M, Cottin Y, Vergely C. 2014. Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta. 1840:2709–2729. doi:10.1016/j.bbagen.2014.05.017.
   PubMed Web of Science ®Google Scholar
• Su S, Li Q, Liu Y, Xiong C, Li J, Zhang R, Niu Y, Zhao L, Wang Y, Guo H. 2014. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway. Toxicol Lett. 224:257–263. doi:10.1016/j.toxlet.2013.10.034.
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. 2007. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 30:1212–1218. doi:10.2337/dc06-2247.
   PubMed Web of Science ®Google Scholar
• Than NN, Tomlinson CL, Haldar D, King AL, Moore D, Newsome PN. 2016. Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol. Syst Rev. 5:100. doi:10.1186/s13643-016-0289-2.
   PubMed Web of Science ®Google Scholar
• Tóbon-Velasco JC, Cuevas E, Torres-Ramos MA. 2014. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 13:1615–1626. doi:10.2174/1871527313666140806144831.
   PubMed Web of Science ®Google Scholar
• Williamson RM, Price JF, Glancy S, Perry E, Nee LD, Hayes PC, Frier BM, Van Look LA, Johnston GI, Reynolds RM, Strachan MW; Edinburgh Type 2 Diabetes Study Investigators. 2011. Prevalence of and risk factors for hepatic steatosis and nonalcoholic fatty liver disease in people with type 2 diabetes: the edinburgh type 2 diabetes study. Diabetes Care. 34:1139–1144. doi:10.2337/dc10-2229.
   PubMed Web of Science ®Google Scholar
• Yang G, Huang Y, Wu X, Lin X, Xu J, Chen X, Bai X, Li Q. 2018. Endogenous secretory receptor for advanced glycation end products protects endothelial cells from AGEs induced apoptosis. Biomed Res Int. 2018:8216578.
   PubMedGoogle Scholar
• Zhang H, Sun Q, Xu T, Hong L, Fu R, Wu J, Ding J. 2016. Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathways. Mol Med Rep. 13:224–230. doi:10.3892/mmr.2015.4497.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Huang WD, Lv XY, Yang YM. 2011. Ghrelin protects H9c2 cells from hydrogen peroxide-induced apoptosis through NF-κB and mitochondria-mediated signaling. Eur J Pharmacol. 654:142–149. doi:10.1016/j.ejphar.2010.12.011.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Deng Q, Zhang J, Ke J, Zhu Y, Wen RW, Ye Z, Peng H, Su ZZ, Wang C, Lou T. 2018. Activation of the Nrf2-ARE pathway ameliorates hyperglycemia-mediated mitochondrial dysfunction in podocytes partly through Sirt1. Cell Physiol Biochem. 48:1–15. doi:10.1159/000491658.
   PubMedGoogle Scholar